Related Topics News -

     
 Detail   |   Print    Next page > 
     
《業績》東陽光藥業中期虧損擴大至6.04億元人民幣
2026-08-31T  
下周備忘
2026-08-28T  
《盈警》東陽光藥料中期虧損增至約5.9億人民幣
2026-08-25T  
東陽光藥甘精胰島素注射液首次美國商業化發貨
2026-08-03T  
東陽光藥控股股東持股增至約51.42%
2026-07-31T  
東陽光藥德谷胰島素注射液獲國家藥監局上市批准
2026-07-31T  
東陽光藥控股股東擬斥最多6億元增持股份 周一回購81.75萬股
2026-07-21T  
東陽光藥甘精胰島素獲FDA批准
2026-07-20T  
《大行》高盛列出具有納入南向交易潛力半新股(表)
2026-06-15T  
東陽光藥甘精胰島素注射液獲FDA上市批准
2026-05-04T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.